AP-1 downregulation has been implicated as part of the mechanism by which administration of IFN-alpha therapy induces depression symptoms.31NF-κβ is a transcription regulator that has a role in peripheral inflammation with both pro- and anti-inflammatory effects.32, 33. Here, FOS is linked to major depressive disorder.